www.eshre2017.eu

Geneva – Switzerland2 to 5 July 2017

POSTERSAll posters will be presented in electronic format and will be on display for three days starting on Monday, 3 July until Wednesday, 5 July in the poster area in Hall 3. Poster discussions will take place on Monday 3 and Tuesday 4 July.

ESHRECOMMUNITYEVENTS

BREAKSCoffee and Lunch breaks will be served in Hall 2 (Exhibit Hall).

Opening Ceremony Sunday, 2 July 19:00 – 20:00 Plenary 1

Welcome Reception Sunday, 2 July 20:00 – 22:00 Hall 2 – Exhibit hall

Charity Run Monday, 3 July 18:30

Annual General Assembly of Members

Tuesday, 4 July 18:00 – 19:00 Room A

Networking Event Tuesday, 4 July 20:00 at BFM

Closing and Award Ceremony

Wednesday, 5 July 15:30 – 16:30 Room W+X

COFFEE Monday to Wednesday from 09:30 to 10:00Monday and Tuesday from 16:30 to 17:00

LUNCH Monday to Wednesday from 13:00 to 14:00

CHECKTHEFULL PROGRAMMEON THECONGRESSAPP

COMPANYSYMPOSIAMonday, 3 July Tuesday, 4 July

11:45 – 13:0014:00 – 15:1517:00 – 18:15

Ferring IBSAGedeon Richter/Finox

11:45 – 13:00 14:00 – 15:15

MerckMSD

COMPANYSESSIONS ANDPRODUCTTHEATRES

Monday, 3 July Tuesday, 4 July

13:00 – 14:0016:00 – 17:00

AYTU BioScience Lo.Li. Pharma International s.r.l.

13:00 – 14:00 Vitrolife

SUNDAY,2JULY2017/PCCPCC 01: Mild, moderate and severe male infertility: What is it all about? - An urgent call for consensus Room X

PCC 02: The role of ultrasound in early pregnancy Room L

PCC 03: Cellular and molecular biology for clinical embryologists Room A

PCC 04: Measuring and enhancing endometrial receptivity to improve pregnancy outcomes Room C

PCC 05: Fertility awareness: What role does it play in preventing infertility? Room U

PCC 06: Ovarian stimulation for IVF: Individualisation and beyond...? Room B

PCC 07: Mitochondria in human reproduction and ART Room W

PCC 08: Complications in reproductive surgery Room F

PCC 09: Transgenderism and reproduction: State of the art in fertility options for transgender and people with sex reassignment Room G

PCC 10: At the crossroad between human embryology and embryonic stem cells: Lessons from molecular and morphological analysis Room E

PCC 11: Where to draw the line Room Q

PCC 12: ASRM exchange course: Procedure and technique for embryo transfer in humans Room R & S

PCC 13: How to present and publish your research? Room V

PCC 14: MEFS exchange course: Is the oocyte the main determinant of embryo quality? Strategies for the selection of the most competent oocyte Room K

PCC 15: Cochrane course: How to prepare a systematic review in reproductive medicine Room T

MONDAY,3JULY2017

INVITED SESSIONS SELECTED ORAL COMMUNICATION SESSIONS

PLENARY 1 PLENARY 2 ROOM A ROOM B ROOM W+X ROOM C

08:30- 09:30

SESSION 01: Keynote Session

10:00- 11:30

SESSION 02: Novel ideas in embryology

SESSION 03: Refining protocols

SESSION 04: The role of genes testis structure in male infertility

SESSION 05: Improving implantation

SESSION 06: Developments in genetic testing

SESSION 07: Long-term consequences in ART

11:45- 12:45

INDUSTRY SPONSORED SYMPOSIUM (until 13:00)

SESSION 08: Ovarian rejuvenation: for real or just a dream?

SESSION 09: Data reporting session

SESSION 10: Fertility Society of Australia Exchange Lecture (until 12:15)

SESSION 11: Paramedical invited session: Sperm messaging - what’s the story?

14:00- 15:00

INDUSTRY SPONSORED SYMPOSIUM (until 15:15)

SESSION 12: The science and ethics behind germline genome editing

SESSION 13: Recent developments in ovarian (hyper) stimulation and ovulation induction

SESSION 14: Debate: Deep endometriosis: to operate or not in infertile women

SESSION 15: Paramedical session - Listening to the patient

15:15-16:30

SESSION 16: Optimizing the embryo environment

SESSION 17: Life-style and preparation for IVF

SESSION 18: Updates on PCOS

SESSION 19: Cryopreservation of oocytes and embryos

SESSION 20: Different types of pluripotent stem cells

SESSION 21: Reproduction after cancer treatment

17:00- 18:00

INDUSTRY SPONSORED SYMPOSIUM (until 18:15)

SESSION 22: Has tran-scriptome analysis of oocytes and embryos run its course? Single cell omics

SESSION 23: Are microwave food containers, water bottles and soft drink cans making you infertile?

SESSION 24: Changing the life course for PCOS

SESSION 25: Paramedical session - Laboratory - Increasing performance

TUESDAY,4JULY2017PLENARY 1 PLENARY 2 ROOM A ROOM B ROOM W + X ROOM C

08:30- 09:30

SESSION 26: Endometrial stem cells: hope and expectation

SESSION 27: Making the best of psycho-social support

SESSION 28: Controversies in cryopreser-vation

SESSION 29: ASRM exchange session

SESSION 30: Paramedical invited session - Providing patients with helpful advice

SESSION 31: WHO session - Addressing the unmet need for infertility services

10:00- 11:30

SESSION 32: Inside the embryo

SESSION 33: Live surgery session

SESSION 34: Drugs and protocols in ART

SESSION 35: Oocytes, donors and outcomes

SESSION 36: An update on sperm function

SESSION 37: Clinical aspects of endometri-osis

11:45- 12:45

INDUSTRY SPONSORED SYMPOSIUM (until 13:00)

SESSION 38: European and global ART monitoring session

SESSION 39: DNA repair in oocytes as a key determinant of reproductive failure

SESSION 40: Progesterone support - examining the evidence

SESSION 41: Paramedical session - Planning a family

14:00- 15:00

INDUSTRY SPONSORED SYMPOSIUM (until 15:15)

SESSION 42: MHR symposium - Transgener-ational programming via the paternal genome

SESSION 43: Endometriosis management - less of the past, more of the future

SESSION 44: Paramedical invited session 3: Debate - “Should we perform PGS on all patients?”

SESSION 45: Patient session: Pushing things forward: accelerating change - Patient association role in MAR

15:15-16:30

SESSION 46: Frontiers of embryology

SESSION 47: What is new in AMH?

SESSION 48: Outcomes and ovarian stimulation

SESSION 49: Factors affecting sperm function

SESSION 50: Mosaicism in gametes and embryos

SESSION 51: Travels through implantation

17:00- 18:00

SESSION 52: New insights into sperm analysis

SESSION 53: Fertility preservation

SESSION 54: Safety and quality issues

SESSION 55: Environment matters

SESSION 56: Reproductive surgery

SESSION 57: Ethics and law

PLENARY 1 PLENARY 2 ROOM A ROOM B ROOM W + X ROOM C

08:30- 09:30

SESSION 58: Cochrane session: Evidence based deci-sion making in fertility treatments

SESSION 59: New sources of gametes

SESSION 60: Paramedical invited session: The oocyte and beyond

10:00- 11:45

SESSION 61: Embryo in motion

SESSION 62: Mutations and primary ovarian insufficiency

SESSION 63: Modifying factors in receptivity

SESSION 64: Patterns of genetic diversity

SESSION 65: Markers and mechanisms of endome-triosis

SESSION 66: Psychology and counselling

12:00-13:00

SESSION 67: From beginning to end: chromosomes made to fail

SESSION 68: Intra-uterine insemination: why, when and how

SESSION 69: Endogenous retroviruses and pregnancy

14:00- 15:15

SESSION 70: Clinical impact of laboratory techniques

SESSION 71: Female (in)fertility - Basic research

SESSION 72: New endocrine interventions

SESSION 73: News and views on clinical andrology

SESSION 74: Endometrium and embryo crosstalk

SESSION 75: From laboratory to clinic

WEDNESDAY,5JULY2017

Transforming fertility managementMonday 3 July 201717.00 – 18.00 Hall 1

AgendanChairmen

Bart CJM Fauser, MD PhD Netherlands

Marc Germond, MD Switzerland

nFibroids and Fertility: from present to future Jacques Donnez, MD PhD Belgium

nSafeguarding fertility: why the debate? Michael Grynberg, MD PhD France

nPreventing Transmission of abnormal Mitochondrial DNA Alison Murdoch, MD FRCOG United Kingdom

Come and visit us at Booth G24

Finox Biotech/ Gedeon Richter Satellite Symposium

176101947 Biotech satellite symp_A6 Ad.indd 1 05/05/2017 16:08